Condition
Acute Bronchitis
Acute bronchitis is inflammation of the airways leading to the lungs, usually set off by a viral infection, and it brings a lingering cough, often with mucus, for one to three weeks. Among supplements, the evidence is strongest for Pelargonium sidoides, and trials found bronchitis symptoms improved, with N-acetylcysteine showing moderate support too. Those pooled results came from a modest number of studies, and the N-acetylcysteine data leaned on a single review that looked at chronic bronchitis.
Sources: PMID 18222667; PMID 22360575; PMID 31598901
- Supplements studied
- 3
- Graded outcomes
- 4
- Trials
- 10
- People studied
- 9,867
Evidence by supplement
- Strong
- Moderate
- Limited
- Very limited
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Bronchitis Symptoms Moderate Improvement | Improves (the measure goes down) | Moderate effect | 4 studies | 1,012 people | ||
Studies that measured bronchitis symptoms
| ||||||
| Appetite Small Increase | Worsens (the measure goes up) | Small effect | 620 people | |||
| Lung Function | Improves (the measure goes up) | 10 studies | 4,241 people | |||
Studies that measured lung function
| ||||||
| Fever | Improves (the measure goes up) | 2 studies | 3,237 people | |||
Studies that measured fever | ||||||
| Common Cold Symptoms | Changes; see studies | 1 study | 693 people | |||
Studies that measured common cold symptoms | ||||||
| Cough | Changes; see studies | 1 study | 719 people | |||
| Fatigue Symptoms | Changes; see studies | 3,641 people | ||||
| Headaches | Changes; see studies | 4,261 people | ||||
| Nausea Symptoms | Changes; see studies | 620 people | ||||
| Subjective Well-Being | Improves (the measure goes up) | 1,111 people | ||||
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Bronchitis Symptoms Small Improvement | Improves (the measure goes down) | Small effect | 1 study | 968 people | ||
Studies that measured bronchitis symptoms | ||||||
| Chronic Bronchitis | Improves (the measure goes up) | 1,564 people | ||||
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Cough Symptom Relief No clinical trials evaluate slippery elm for cough suppression or relief. Traditional use as a demulcent for coughs is long-standing, and the mucilage coating mechanism is plausible for soothing irritated upper airways, but no modern clinical data supports this indication specifically. | Improves (the measure goes down) | Small effect |
Key findings
- Bronchitis SymptomsImproves (the measure goes down)
- AppetiteWorsens (the measure goes up)
- Cough Symptom ReliefImproves (the measure goes down)
The Acute Bronchitis Support protocol
2 primary supplements · 7 supporting supplements
- Pelargonium sidoides (Umckaloabo)EPs 7,630 extract: 30 drops or 1.5 mL 3 times daily for 7–14 days
- N-Acetylcysteine (NAC)600–1,200 mg daily in divided doses
Shop the evidence-backed picks
The collection holds the supplements we grade A or B for its theme, in third-party tested products where the catalog has them. It opens in our Fullscript store. You can look through it without signing in; Fullscript asks for a free account to order.
Or shop one supplement
The supplements graded A or B for Acute Bronchitis. Each opens third-party tested products for that supplement.
- Grade A
- Grade B
We earn from purchases made in our Fullscript store, and links to Fullscript, iHerb or Thorne carry our referral, so we may earn a commission at no extra cost to you. Grades come from the research and never change based on what we earn. Full disclosure
Studies cited
58 studies from PubMed
- Characterisation of phenolics in Flor-Essence--a compound herbal product and its contributing herbs.
- Immunomodulatory activity of Ulmus davidiana Planch (Ulmaceae) water and ethanolic extracts on bone cells: Stimulation of proliferation, alkaline phosphatase activity and type I collagen synthesis.
- Safety and tolerability of N-acetylcysteine in cocaine-dependent individuals
- The administration of N-acetylcysteine reduces oxidative stress and regulates glutathione metabolism in the blood cells of workers exposed to lead
- N-Acetylcysteine Attenuates Fatigue Following Repeated-Bouts of Intermittent Exercise: Practical Implications for Tournament Situations
- N-acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: a double-blind, placebo-controlled study
- New developments in the treatment of COPD: comparing the effects of inhaled corticosteroids and N-acetylcysteine
- Induced sputum of patients with chronic obstructive pulmonary disease (COPD) contains adhesion-promoting, therapy-sensitive factors
- N-acetylcysteine add-on treatment in refractory obsessive-compulsive disorder: a randomized, double-blind, placebo-controlled trial
- Systematic review and meta-analysis of the efficacy of N-acetylcysteine in the treatment of acute exacerbation of chronic obstructive pulmonary disease.
- Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial
- Long-term oral n-acetylcysteine reduces exhaled hydrogen peroxide in stable COPD
- The efficacy of -acetylcysteine in chronic obstructive pulmonary disease patients: a meta-analysis.
- Effect of Orally Administered N-Acetylcysteine on Chronic Bronchitis: A Meta-analysis.
- A randomized controlled pilot trial of oral N-acetylcysteine in children with autism
- A randomized double blind placebo controlled clinical trial of N-Acetylcysteine added to risperidone for treating autistic disorders
- N-Acetylcysteine (NAC) inhibits renal nitrite and nitrate reabsorption in healthy subjects and in patients undergoing cardiac surgery: risk of nitric oxide (NO) bioavailability loss by NAC?
- The role of cystine-glutamate exchange in nicotine dependence in rats and humans
- N-acetylcysteine (NAC) in young marijuana users: an open-label pilot study
- N-Acetylcysteine in depressive symptoms and functionality: a systematic review and meta-analysis.
- N-acetylcysteine in the treatment of craving in substance use disorders: Systematic review and meta-analysis.
- Meta-analysis of randomised controlled trials with -acetylcysteine in the treatment of schizophrenia.
- Meta-analytic Techniques to Assess the Association Between N-acetylcysteine and Acute Kidney Injury After Contrast Administration: A Systematic Review and Meta-analysis.
- The efficacy of adjuvant N acetyl cysteine for the eradication of H pylori infections: A systematic review and meta-analysis of randomized clinical trials.
- N-acetylcysteine in the Donor, Recipient, or Both Donor and Recipient in Liver Transplantation: A Systematic Review With Meta-analysis and Trial Sequential Analysis.
- N-acetylcysteine use among patients undergoing cardiac surgery: A systematic review and meta-analysis of randomized trials.
- The effect of N-acetylcysteine on bipolar depression: a systematic review and meta-analysis of randomized controlled trials.
- N-acetylcysteine as an adjunctive treatment for bipolar depression: A systematic review and meta-analysis of randomized controlled trials.
- N-acetylcysteine as an adjunctive treatment for bipolar depression and major depressive disorder: a systematic review and meta-analysis of double-blind, randomized placebo-controlled trials.
- Efficacy and Safety of N-Acetylcysteine for the Management of Chronic Pain in Adults: A Systematic Review and Meta-Analysis.
- The effects of N-acetylcysteine on ovulation and sex hormones profile in women with polycystic ovary syndrome: a systematic review and meta-analysis
- The effects of N-acetylcysteine supplement on metabolic parameters in women with polycystic ovary syndrome: a systematic review and meta-analysis.
- A systematic review and meta-analysis of the efficacy and safety of N-acetylcysteine in preventing aminoglycoside-induced ototoxicity: implications for the treatment of multidrug-resistant TB.
- Effect of N-acetyl-cysteine in prevention of noise-induced hearing loss: a systematic review and meta-analysis of randomized controlled trials.
- Effect of N-acetyl-cysteine treatment on sensorineural hearing loss: a meta-analysis.
- No Significant Beneficial Effects of Intravenous N-Acetylcysteine on Patient Outcome in Non-Paracetamol Acute Liver Failure: A Meta-Analysis of Randomized Controlled Trials.
- Treatment of acute bronchitis in adults with a pelargonium sidoides preparation (EPs 7630): a randomized, double-blind, placebo-controlled trial
- EPs 7630 improves acute bronchitic symptoms and shortens time to remission. Results of a randomised, double-blind, placebo-controlled, multicentre trial
- Pelargonium sidoides preparation (EPs 7630) in the treatment of acute bronchitis in adults and children
- Efficacy and tolerability of EPs 7630 in patients (aged 6-18 years old) with acute bronchitis
- Efficacy and tolerability of EPs 7630 tablets in patients with acute bronchitis: a randomised, double-blind, placebo-controlled dose-finding study with a herbal drug preparation from Pelargonium sidoides
- EPs 7630-solution--an effective therapeutic option in acute and exacerbating bronchitis
- Treatment of acute bronchitis with a liquid herbal drug preparation from Pelargonium sidoides (EPs 7630): a randomised, double-blind, placebo-controlled, multicentre study
- Efficacy and safety of an extract of Pelargonium sidoides (EPs 7630) in adults with acute bronchitis. A randomised, double-blind, placebo-controlled trial
- Efficacy and tolerability of EPs 7630 in children and adolescents with acute bronchitis - a randomized, double-blind, placebo-controlled multicenter trial with a herbal drug preparation from Pelargonium sidoides roots
- Pelargonium sidoides for acute bronchitis: a systematic review and meta-analysis
- Treatment of acute bronchitis with EPs 7630: randomized, controlled trial in children and adolescents
- Effects of Pelargonium sidoides extract EPs 7630 on acute cough and quality of life - a meta-analysis of randomized, placebo-controlled trials.
- Treatment of acute rhinosinusitis with the preparation from Pelargonium sidoides EPs 7630: a randomized, double-blind, placebo-controlled trial
- Can the Pelargonium sidoides root extract EPs® 7630 prevent asthma attacks during viral infections of the upper respiratory tract in children
- Herbal Medicine for Cough: a Systematic Review and Meta-Analysis.
- Randomised, double-blind, placebo-controlled trial of EPs 7630 in adults with COPD
- Efficacy of a pelargonium sidoides preparation in patients with the common cold: a randomized, double blind, placebo-controlled clinical trial
- The efficacy of Pelargonium sidoides in the treatment of upper respiratory tract infections in children with transient hypogammaglobulinemia of infancy
- Treatment of signs and symptoms of the common cold using EPs 7630 - results of a meta-analysis.
- Immune responses induced by Pelargonium sidoides extract in serum and nasal mucosa of athletes after exhaustive exercise: modulation of secretory IgA, IL-6 and IL-15
- Herbal Medicine in Children With Respiratory Tract Infection: Systematic Review and Meta-Analysis.
- Pelargonium sidoides extract for treating acute respiratory tract infections.